Precision medicine treatment in older AML: Results of Beat AML master trial

Older patients with non-Hodgkin lymphoma can be treated successfully with CAR T-cell therapy

Depth of response to daratumumab, lenalidomide, bortezomib, and dexamethasone improves over time in transplant-eligible newly diagnosed multiple myeloma

CARTITIUDE-1: BCMA-targeted CAR T-cell therapy shows high response rates in patients with multiple myeloma

Blinatumomab vs chemotherapy as post-reinduction therapy in HR/IR first relapse of B-ALL in children and adolescents

Identifying prognostic constellations of driver mutations in acute myeloid leukaemia and myelodysplastic syndromes

CANDOR: Triple drug combo delays disease progression in stubborn multiple myeloma

Maintenance therapy with CC-486 for acute myeloid leukaemia

Daratumuab, carfilzomib and dexamethasone increases survival in patients with relapsed/refractory multiple myeloma

Exploring the pathogenesis of AML and myelodysplastic syndromes using genome and transcriptome sequencing

QUAZAR AML-001: Evaluating CC-486 as a maintenance therapy for older patients with acute myeloid leukaemia in first remission

Blinatumomab demonstrates superior efficacy compared to chemotherapy in children and young adults with relapsed B-ALL